USMLE Step 1 Biochemistry High-Yield Facts

Mastering biochemistry is non-negotiable for USMLE Step 1 success. This high-stakes exam consistently tests your ability to connect basic science principles to clinical disease presentations. Your recall of enzyme deficiencies, pathway regulation, and classic mnemonics will directly translate to points on test day, forming the foundation for understanding pharmacology and pathology in later steps.

Glycogen Storage Diseases: Structure, Function, and Failure

Glycogen storage diseases (GSDs) are a classic group of inborn errors of metabolism caused by deficiencies in enzymes responsible for glycogen synthesis or breakdown. They are categorized based on the affected enzyme and the resulting clinical picture, which often revolves around hypoglycemia or glycogen accumulation in specific organs.

A crucial framework is to separate GSDs by the primary site of pathology: liver or muscle. GSD I (von Gierke's disease), caused by a deficiency in glucose-6-phosphatase, is the prototypical liver GSD. Patients present with severe fasting hypoglycemia, lactic acidosis, hyperlipidemia, and hepatomegaly. The hypoglycemia occurs because the final step of both glycogenolysis and gluconeogenesis is blocked. In contrast, GSD V (McArdle's disease), a deficiency in muscle glycogen phosphorylase, is a pure myopathy. Patients experience exercise intolerance, muscle cramps, and myoglobinuria with vigorous activity, but have a normal blood glucose response. A key mnemonic for the enzyme in McArdle's is "Myophosphorylase."

Other high-yield GSDs include GSD II (Pompe disease), a lysosomal storage disorder (acid alpha-1,4-glucosidase deficiency) causing cardiomegaly and early death, and GSD III (Cori disease), a debranching enzyme deficiency that presents similarly to von Gierke's but is milder. For Step 1, be prepared to match the enzyme defect, inheritance pattern (mostly autosomal recessive), and the classic lab findings or presentation vignette.

Lysosomal Storage Diseases: The "Sphingo-lipid-oses"

Lysosomal storage diseases result from deficient lysosomal enzymes, leading to the accumulation of undegraded substrates within the lysosome. They are overwhelmingly autosomal recessive, with the notable exception of Hunter syndrome (MPS II), which is X-linked recessive. The clinical hallmark is progressive neurological deterioration, organomegaly (especially hepatosplenomegaly), and coarse facial features, though the specific signs point to the diagnosis.

You must know the enzyme, accumulated substrate, and key distinguishing feature for each. For example:

• Tay-Sachs disease: Hexosaminidase A deficiency. Accumulates GM2 ganglioside. Presents with cherry-red spot on macula, neurodegeneration, and is prevalent in Ashkenazi Jews.
• Niemann-Pick disease: Sphingomyelinase deficiency. Accumulates sphingomyelin. Presents with cherry-red spot and hepatosplenomegaly.
• Gaucher disease: Glucocerebrosidase deficiency. Accumulates glucocerebroside. Presents with crumpled tissue paper histology, hepatosplenomegaly, and bone crises. The mnemonic "Gaucher cells look Glassy" can help recall the histology.
• Fabry disease: Alpha-galactosidase A deficiency. Accumulates ceramide trihexoside. Presents with angiokeratomas, burning peripheral neuropathy, and renal/cardiac disease. It is X-linked.

The mnemonic for the general lysosomal disease presentation is common testable content: "Hepatosplenomegaly, Organomegaly, Progressive neurodegeneration, Enzyme replacement therapy is possible, Sphingolipidoses." Recognizing the pattern of inheritance and the specific visual or histological clue is the key to answering these questions quickly.

Amino Acid Metabolism and Vitamin Co-Factor Essentials

Disorders of amino acid metabolism are prime Step 1 material, often presented as a neonate with abnormal urine odor, neurological issues, or metabolic acidosis. The regulation of these pathways is equally important.

• Phenylketonuria (PKU): Deficiency of phenylalanine hydroxylase (or its co-factor tetrahydrobiopterin, BH4). Leads to intellectual disability, microcephaly, and musty/mousy body odor. Treatment is a low-phenylalanine diet. Remember, the accumulating phenylalanine gets transaminated to phenylpyruvate (the phenylketone in the urine).
• Maple Syrup Urine Disease: Deficiency in the branched-chain alpha-ketoacid dehydrogenase complex. Leads to accumulation of leucine, isoleucine, and valine, causing severe cerebral edema, ketoacidosis, and a classic maple syrup odor in urine and sweat.
• Homocystinuria: Most commonly caused by a deficiency in cystathionine synthase, which uses vitamin B6 (pyridoxine) as a co-factor. Patients present with marfanoid habitus (tall, long limbs), intellectual disability, lens dislocation (downward and inward), and hypercoagulable state leading to thromboembolism. This contrasts with Marfan syndrome, which features lens dislocation upward and outward.

The regulation of the urea cycle is another high-yield area. Carbamoyl phosphate synthetase I (CPS I) is the rate-limiting and first committed step, requiring N-acetylglutamate as an allosteric activator. N-acetylglutamate is synthesized by N-acetylglutamate synthase in response to high arginine levels, linking amino acid catabolism to urea production.

Vitamin Deficiencies: From Co-Factors to Clinical Scenarios

Vitamins act as essential co-factors for enzymes. Their deficiencies disrupt critical pathways, producing recognizable clinical syndromes. Step 1 tests these associations relentlessly.

• Thiamine (B1): Co-factor for alpha-ketoglutarate dehydrogenase and transketolase. Deficiency causes Beriberi (wet=dilated cardiomyopathy; dry=peripheral neuropathy) and Wernicke-Korsakoff syndrome (confusion, ataxia, ophthalmoplegia/amnesia).
• Pyridoxine (B6): Co-factor for transaminases and decarboxylases. Deficiency causes convulsions, peripheral neuropathy, and sideroblastic anemia. It is also a treatment for isoniazid toxicity and certain homocystinurias.
• Cobalamin (B12) and Folate (B9): Both are essential for homocysteine methylation to methionine and for DNA synthesis. B12 deficiency additionally causes subacute combined degeneration (demyelination of dorsal columns and lateral corticospinal tracts) due to its role in converting methylmalonyl-CoA to succinyl-CoA. Folate deficiency does not cause neurological symptoms. The methylmalonic acid (MMA) level is key: elevated in B12 deficiency, normal in folate deficiency.
• Vitamin C: Essential for proline and lysine hydroxylation during collagen synthesis. Deficiency causes scurvy: swollen gums, poor wound healing, perifollicular hemorrhages, and corkscrew hairs.

Collagen, Purines, and Pyrimidines: Synthesis and Pathology

Collagen synthesis follows a precise intracellular and extracellular process. A key disorder is Ehlers-Danlos syndrome, often involving defects in collagen structure or processing, leading to hyperextensible skin, hypermobile joints, and easy bruising. Osteogenesis imperfecta, the "brittle bone disease," is typically caused by mutations in type I collagen.

Disorders of purine and pyrimidine metabolism are tested through their unique enzyme defects and drug toxicities.

• Lesch-Nyhan syndrome: X-linked deficiency of HGPRT (hypoxanthine-guanine phosphoribosyltransferase). This disrupts the purine salvage pathway, leading to overproduction of uric acid. Patients present with hyperuricemia, gout, self-mutilating behavior, and intellectual disability.
• Orotic aciduria: Deficiency in UMP synthase (a bifunctional enzyme of the de novo pyrimidine synthesis pathway). This causes megaloblastic anemia that does not respond to B12 or folate, and orotic acid crystals in urine. It is treatable with uridine supplementation.
• ADA/PNP deficiency: Deficiencies in adenosine deaminase and purine nucleoside phosphorylase cause severe combined immunodeficiency (SCID) due to toxic accumulation of metabolites (deoxyadenosine and dGTP) in lymphocytes.

For drug associations, know that 5-fluorouracil (5-FU) inhibits thymidylate synthase, blocking dTMP synthesis. Methotrexate inhibits dihydrofolate reductase, depleting tetrahydrofolate needed for nucleotide synthesis. Allopurinol inhibits xanthine oxidase, used to treat gout and tumor lysis syndrome to prevent uric acid buildup.

Common Pitfalls

1. Confusing Tay-Sachs and Niemann-Pick: Both can have a cherry-red spot. Remember that Tay-Sachs is a neurodegenerative disease with no hepatosplenomegaly, while Niemann-Pick prominently features hepatosplenomegaly. The accumulated substrates (GM2 vs. sphingomyelin) are also different.
2. Mixing up Homocystinuria and Marfan Syndrome: Both can have a tall, slender build and lens dislocation. The critical discriminator is the direction of lens dislocation (down & in for homocystinuria, up & out for Marfan) and the presence of a hypercoagulable state only in homocystinuria.
3. Forgetting the Vitamin C Connection: It's easy to recall bleeding gums for scurvy, but forgetting that the root cause is defective collagen hydroxylation is a missed opportunity for a deeper integrative question.
4. Misidentifying the Salvage Pathway Enzyme: Confusing APRT (adenine phosphoribosyltransferase) with HGPRT. Lesch-Nyhan is HGPRT deficiency. APRT deficiency causes adenine stones but not the neurological/behavioral syndrome.

Summary

• Glycogen Storage Diseases are categorized by affected organ (liver vs. muscle); know von Gierke's (GSD I, hypoglycemia) and McArdle's (GSD V, myopathy) as opposites.
• Lysosomal Storage Diseases are mostly autosomal recessive, involving specific enzyme-substrate pairs; key identifiers include cherry-red spots (Tay-Sachs, Niemann-Pick), X-linked inheritance (Hunter, Fabry), and distinctive histology (Gaucher).
• High-yield amino acid disorders include PKU (musty odor, intellectual disability), Maple Syrup Urine Disease (ketoacidosis, cerebral edema), and Homocystinuria (marfanoid habitus, thrombosis, lens dislocation).
• Vitamin deficiencies disrupt specific pathways: B1 (Wernicke, beriberi), B12 (megaloblastic anemia + neurological symptoms, elevated MMA), B6 (neuropathy, sideroblastic anemia), and Vitamin C (scurvy from impaired collagen synthesis).
• Purine/pyrimidine disorders have unique presentations: Lesch-Nyhan (HGPRT, hyperuricemia, self-mutilation), Orotic Aciduria (UMP synthase, megaloblastic anemia unresponsive to B12/folate), and ADA/PNP deficiency (SCID).